Genetic Determinants: Elastin Quality and Quantity

遗传决定因素:弹性蛋白的质量和数量

基本信息

  • 批准号:
    7231246
  • 负责人:
  • 金额:
    $ 42.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-12-01 至 2011-11-30
  • 项目状态:
    已结题

项目摘要

Sensitivity to cigarette smoke-induced COPD is highly variable. Many genetic and environmental factors that are thought to be responsible for this natural variation, however, remain unidentified. Our preliminary results suggest that the level of elastin in the lung is critical for normal lung development and for timely and efficient repair following injury. When elastin levels are below a critical threshold, repair is unproductive and the lungs are more prone to develop COPD. Moreover, we have found that patients with mutations in the elastin gene (ELN) develop severe, very early onset bronchiectasis, emphysema and end-stage lung disease. Rare variants of elastin could also predispose to enhanced lung damage by affecting the quality of the elastic fiber. In this case, minor alterations in elastin processing or assembly could support normal lung development and function but result in fibers that have increased susceptibility to degradation by proteases. The central hypothesis of this proposal is that the quality and quantity of pulmonary elastin is a critical factor in determining susceptibility to cigarette smoke-induced lung damage, leading to COPD. This hypothesis is supported by preliminary data indicating that both quantitative and qualitative deficiency in elastin can predispose to smoke-induced emphysema in both animal models and in inherited syndromes in humans caused by ELN mutations. The goal of this proposal is to uncover the mechanisms by which elastin defects result in COPD, and to assess mutations and variants in ELN as risk factors of COPD. To achieve these goals we propose the following specific aims: Aim 1. To test if human genetic diseases caused by mutations in ELN are associated with an increased risk of COPD. Aim 2. To test whether genetic variants present in the normal population (a) alter ELN function and (b) are associated with quantitative outcome measures in patients with severe emphysema. Aim 3: To test if lower than normal levels of lung elastin resulting from genetic or environmental factors lead to increased susceptibility to COPD. Aim 4. To test if qualitative alterations in pulmonary elastin arising from rare elastin variants contribute to COPD susceptibility.
对香烟烟雾诱导的COPD的敏感性是高度可变的。许多遗传和环境因素 然而,被认为是造成这种自然变异的原因仍然没有得到确认。我们的初步 结果表明,肺中弹性蛋白的水平对于肺的正常发育和及时 损伤后的有效修复。当弹性蛋白水平低于临界阈值时,修复是无效的, 肺部更容易发展为COPD。此外,我们还发现, 弹性蛋白基因(ELN)发展严重的,非常早发型支气管扩张,肺气肿和终末期肺 疾病罕见的弹性蛋白变体也可能通过影响肺组织的质量而使肺损伤加重。 弹性纤维。在这种情况下,弹性蛋白加工或组装的微小改变可以支持正常的肺 发育和功能,但导致纤维对蛋白酶降解的敏感性增加。 该建议的中心假设是,肺弹性蛋白的质量和数量是一个关键因素。 决定吸烟引起的肺损伤易感性的因素,导致COPD。这 初步数据支持了这一假设,表明在数量和质量上都存在缺陷, 在动物模型和遗传性综合征中,弹性蛋白都能使吸烟引起的肺气肿易感。 由ELN突变引起的人类疾病。这项提案的目标是揭示弹性蛋白 ELN的突变和变异导致COPD,并评估ELN的突变和变异作为COPD的危险因素。实现 这些目标,我们提出以下具体目标:目标1。为了测试人类遗传疾病是否由 ELN突变与COPD风险增加相关。目标二。为了测试基因变异是否 存在于正常人群中(a)改变ELN功能和(B)与定量结果相关 严重肺气肿患者的治疗措施。目的3:测试肺弹性蛋白是否低于正常水平 遗传或环境因素导致对COPD的易感性增加。目标4。以测试是否 由罕见弹性蛋白变异引起的肺弹性蛋白质的改变有助于COPD 易感性

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT P. MECHAM其他文献

ROBERT P. MECHAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT P. MECHAM', 18)}}的其他基金

Vessel Stiffening, Hypertension and Vascular Extracellular Matrix
血管硬化、高血压和血管细胞外基质
  • 批准号:
    9053512
  • 财政年份:
    2010
  • 资助金额:
    $ 42.46万
  • 项目类别:
VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIX
血管硬化、高血压和血管细胞外基质
  • 批准号:
    8016390
  • 财政年份:
    2010
  • 资助金额:
    $ 42.46万
  • 项目类别:
Vessel Stiffening, Hypertension and Vascular Extracellular Matrix
血管硬化、高血压和血管细胞外基质
  • 批准号:
    8886630
  • 财政年份:
    2010
  • 资助金额:
    $ 42.46万
  • 项目类别:
VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIX
血管硬化、高血压和血管细胞外基质
  • 批准号:
    8306069
  • 财政年份:
    2010
  • 资助金额:
    $ 42.46万
  • 项目类别:
VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIX
血管硬化、高血压和血管细胞外基质
  • 批准号:
    8145303
  • 财政年份:
    2010
  • 资助金额:
    $ 42.46万
  • 项目类别:
VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIX
血管硬化、高血压和血管细胞外基质
  • 批准号:
    8502544
  • 财政年份:
    2010
  • 资助金额:
    $ 42.46万
  • 项目类别:
Vessel Stiffening, Hypertension and Vascular Extracellular Matrix
血管硬化、高血压和血管细胞外基质
  • 批准号:
    9223725
  • 财政年份:
    2010
  • 资助金额:
    $ 42.46万
  • 项目类别:
VESSEL STIFFENING, HYPERTENSION, AND VASCULAR EXTRACELLULAR MATRIX
血管硬化、高血压和血管细胞外基质
  • 批准号:
    9174403
  • 财政年份:
    2010
  • 资助金额:
    $ 42.46万
  • 项目类别:
ELASTIN IN VESSEL DEVELOPMENT & VASCULAR DISEASES
弹性蛋白在血管发育中的作用
  • 批准号:
    8277322
  • 财政年份:
    2004
  • 资助金额:
    $ 42.46万
  • 项目类别:
ELASTIN IN VESSEL DEVELOPMENT & VASCULAR DISEASES
弹性蛋白在血管发育中的作用
  • 批准号:
    7914163
  • 财政年份:
    2004
  • 资助金额:
    $ 42.46万
  • 项目类别:

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 42.46万
  • 项目类别:
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 42.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
  • 批准号:
    10677169
  • 财政年份:
    2023
  • 资助金额:
    $ 42.46万
  • 项目类别:
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
  • 批准号:
    10736228
  • 财政年份:
    2023
  • 资助金额:
    $ 42.46万
  • 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 42.46万
  • 项目类别:
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
肝肺综合征低氧血症的新肺泡机制
  • 批准号:
    10718446
  • 财政年份:
    2023
  • 资助金额:
    $ 42.46万
  • 项目类别:
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 42.46万
  • 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
  • 批准号:
    10638221
  • 财政年份:
    2023
  • 资助金额:
    $ 42.46万
  • 项目类别:
Alveolar Epithelial Cell Dysfunction Induced By Flavored E-Cigarette Aerosols
加味电子烟气雾剂引起的肺泡上皮细胞功能障碍
  • 批准号:
    10770080
  • 财政年份:
    2023
  • 资助金额:
    $ 42.46万
  • 项目类别:
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
  • 批准号:
    10634881
  • 财政年份:
    2023
  • 资助金额:
    $ 42.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了